Episode Details

CAR-T therapy, where someone’s own immune cells are trained to go after their cancer, has now been shown to confer a heightened infection risk, and risk of death from infection, for some recipients. Johns Hopkins Kimmel Cancer Center director William …

How does infection risk relative to CAR-T treatment factor into therapy? Elizabeth Tracey reports Read More »